Facebook
Linkedin
Tumblr
Twitter
Sign in
My Account
orders
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Password recovery
Recover your password
your email
Search
Sign in / Join
Facebook
Linkedin
Tumblr
Twitter
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Password recovery
Recover your password
your email
A password will be e-mailed to you.
Market Exclusive
My Account
orders
Home
Tags
NYSE:MRK
Tag: NYSE:MRK
Trials Of Agenus Inc (NASDAQ:AGEN) Cancer Vaccine Ends In Absolute Failure
-
February 23, 2017
0
Bristol-Myers Squibb Co (NYSE:BMY), Merck & Co., Inc. (NYSE:MRK), And Other...
-
February 21, 2017
0
Merck & Co., Inc. (NYSE:MRK) HPV Vaccine Gardasil Sales Impress, But...
Andy Parker
-
February 10, 2017
0
The FDA Accepts Keytruda From Merck & Co., Inc. (NYSE:MRK) For...
Andy Parker
-
February 7, 2017
0
The European Medicines Agency (EMA) Recommends KEYTRUDA From Merck & Co.,...
Andy Parker
-
February 1, 2017
0
Pharmaceutical Executives From Merck & Co., Inc. (NYSE:MRK), Johnson & Johnson...
Andy Parker
-
February 1, 2017
0
Merck & Co., Inc.(NYSE:MRK) Is Among Many Drugmakers Being Criticized For...
-
January 30, 2017
0
Bristol-Myers Squibb Co (NYSE:BMY) To Share In Sales Of Merck &...
Andy Parker
-
January 24, 2017
0
Agenus Inc (NASDAQ:AGEN) Incorporates NCI In Evaluation of Prophage-Keytruda Combo
Andy Parker
-
January 19, 2017
0
Merck & Co., Inc. (NYSE:MRK) Joins Forces With M2Gen To Explore...
-
January 6, 2017
0
1
...
6
7
8
...
10
Page 7 of 10